Doxorubicin is a potent anthracycline antibiotic used in cancer chemotherapy, known for its ability to intercalate DNA and inhibit topoisomerase II, leading to disruption of DNA replication and transcription. Despite its efficacy, its use is limited by dose-dependent cardiotoxicity, necessitating careful monitoring and management of cumulative doses.